Published in Br J Ophthalmol on November 01, 2004
Norrin, frizzled-4, and Lrp5 signaling in endothelial cells controls a genetic program for retinal vascularization. Cell (2009) 2.63
The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol Med (2010) 1.38
Coats' disease in Tanzania: first case report and literature review. Afr Health Sci (2014) 0.77
The molecular biology of Norrie's disease. Eye (Lond) (1994) 1.60
Vascular defects and sensorineural deafness in a mouse model of Norrie disease. J Neurosci (2002) 1.44
Retinal vasculature changes in Norrie disease mice. Invest Ophthalmol Vis Sci (1998) 1.33
The ocular pathology of Norrie disease in a fetus of 11 weeks' gestational age. Graefes Arch Clin Exp Ophthalmol (1992) 1.05
Norrie disease gene mutation in a large Costa Rican kindred with a novel phenotype including venous insufficiency. Hum Mutat (1997) 0.95
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res (2001) 8.38
Microarray based comparative genomic hybridisation (array-CGH) detects submicroscopic chromosomal deletions and duplications in patients with learning disability/mental retardation and dysmorphic features. J Med Genet (2004) 5.76
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Clinical features and natural history of von Hippel-Lindau disease. Q J Med (1990) 4.71
The genetics of childhood cataract. J Med Genet (2000) 3.99
Corticobasal degeneration. Brain (1989) 3.20
A human homolog of yeast pre-mRNA splicing gene, PRP31, underlies autosomal dominant retinitis pigmentosa on chromosome 19q13.4 (RP11). Mol Cell (2001) 3.07
A new locus for autosomal dominant retinitis pigmentosa on chromosome 7p. Nat Genet (1993) 2.97
Neuronal loss in the frontal cortex in HIV infection. Lancet (1991) 2.71
Smoking and age related macular degeneration: the number of pack years of cigarette smoking is a major determinant of risk for both geographic atrophy and choroidal neovascularisation. Br J Ophthalmol (2006) 2.67
Vibration and praise as reinforcers for mentally handicapped people. Ment Retard (1978) 2.38
The effect of chemical treatments of albumin and orosomucoid on rate of clearance from the rat bloodstream and rate of pinocytic capture of rat yolk sac cultured in vitro. Biochem J (1977) 2.36
X linked retinoschisis. Br J Ophthalmol (1995) 2.13
PAX6 haploinsufficiency causes cerebral malformation and olfactory dysfunction in humans. Nat Genet (2001) 2.05
Clinical features in affected individuals from 21 pedigrees with dominant optic atrophy. Arch Ophthalmol (1998) 1.93
Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy. Hum Mol Genet (1998) 1.84
The cone dysfunction syndromes. Br J Ophthalmol (2004) 1.76
Phenotypic expression in von Hippel-Lindau disease: correlations with germline VHL gene mutations. J Med Genet (1996) 1.76
Macular hole opercula. Ultrastructural features and clinicopathological correlation. Arch Ophthalmol (1997) 1.73
Clinical features in affected males with X-linked retinoschisis. Arch Ophthalmol (1996) 1.73
Identification of a sixth locus for autosomal dominant retinitis pigmentosa on chromosome 19. Hum Mol Genet (1994) 1.71
Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21. Genomics (1997) 1.70
A novel GJA8 mutation is associated with autosomal dominant lamellar pulverulent cataract: further evidence for gap junction dysfunction in human cataract. J Med Genet (2006) 1.68
Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol (1991) 1.67
Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol (1999) 1.64
A locus for autosomal dominant posterior polar cataract on chromosome 1p. Hum Mol Genet (1997) 1.57
Plasma levels of matrix metalloproteinase-2 and -9 (MMP-2 and MMP-9) in age-related macular degeneration. Eye (Lond) (2007) 1.55
Lens biology: development and human cataractogenesis. Trends Genet (1999) 1.55
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
A locus for autosomal dominant anterior polar cataract on chromosome 17p. Hum Mol Genet (1996) 1.51
Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J Med Genet (2002) 1.44
Achromatopsia caused by novel mutations in both CNGA3 and CNGB3. J Med Genet (2004) 1.44
Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK. Br J Ophthalmol (2007) 1.41
Molecular genetic analysis of the 3p- syndrome. Hum Mol Genet (1994) 1.40
Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol (2007) 1.40
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
A novel connexin50 mutation associated with congenital nuclear pulverulent cataracts. J Med Genet (2007) 1.35
How to predict proliferative vitreoretinopathy: a prospective study. Ophthalmology (2001) 1.33
Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy. J Med Genet (1998) 1.33
Genetic counselling in X-linked ocular albinism: clinical features of the carrier state. Eye (Lond) (1992) 1.32
Histiocytosis X: an ophthalmological review. Br J Ophthalmol (1985) 1.30
Clinical features of affected males with X linked ocular albinism. Br J Ophthalmol (1993) 1.30
X-linked retinoschisis: clinical phenotype and RS1 genotype in 86 UK patients. J Med Genet (2005) 1.30
Characterization of the G91del CRYBA1/3-crystallin protein: a cause of human inherited cataract. Hum Mol Genet (2004) 1.29
Fibrous dysplasia of the orbit in childhood. Clinical features and management. Ophthalmology (1985) 1.26
Autosomal dominant cone-rod dystrophy with mutations in the guanylate cyclase 2D gene encoding retinal guanylate cyclase-1. Arch Ophthalmol (2001) 1.24
Genetic mapping in Methylophilus methylotrophus AS1. J Gen Microbiol (1983) 1.22
Preschool vision screening: outcome of children referred to the hospital eye service. Br J Ophthalmol (1996) 1.21
Autosomal dominant cone-rod retinal dystrophy (CORD6) from heterozygous mutation of GUCY2D, which encodes retinal guanylate cyclase. Ophthalmology (2000) 1.20
Infantile presentation of X linked retinoschisis. Br J Ophthalmol (1995) 1.20
Interpersonal support amongst nurses at work. J Adv Nurs (1986) 1.18
Identification of the gene for Nance-Horan syndrome (NHS). J Med Genet (2004) 1.17
Blue cone monochromatism: a phenotype and genotype assessment with evidence of progressive loss of cone function in older individuals. Eye (Lond) (2005) 1.16
The cone dystrophies. Eye (Lond) (1998) 1.15
The genetics of inherited macular dystrophies. J Med Genet (2003) 1.14
Accumulation of tissue inhibitor of metalloproteinases-3 in human eyes with Sorsby's fundus dystrophy or retinitis pigmentosa. Br J Ophthalmol (1998) 1.14
Audit of cost and clinical outcome of cataract surgery. Health Trends (1994) 1.14
Repeated injections of a ciliary neurotrophic factor analogue leading to long-term photoreceptor survival in hereditary retinal degeneration. Invest Ophthalmol Vis Sci (1999) 1.14
Cortical Lewy body dementia: clinical features and classification. J Neurol Neurosurg Psychiatry (1989) 1.14
Cone and cone-rod dystrophies. J Med Genet (1992) 1.13
A detailed phenotypic study of "cone dystrophy with supernormal rod ERG". Br J Ophthalmol (2005) 1.13
Bimodal expressivity in dominant retinitis pigmentosa genetically linked to chromosome 19q. Br J Ophthalmol (1995) 1.12
Differential allelic expression of a fibrillin gene (FBN1) in patients with Marfan syndrome. Am J Hum Genet (1994) 1.12
Genetic susceptibility to age related macular degeneration. J Med Genet (2000) 1.11
Further refinement of the location for autosomal dominant retinitis pigmentosa on chromosome 7p (RP9). Am J Hum Genet (1994) 1.11
Age related macular degeneration and sun exposure, iris colour, and skin sensitivity to sunlight. Br J Ophthalmol (2006) 1.11
A locus for isolated cataract on human Xp. J Med Genet (2002) 1.11
Clustering and frequency of mutations in the retinal guanylate cyclase (GUCY2D) gene in patients with dominant cone-rod dystrophies. J Med Genet (2001) 1.11
Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry (1993) 1.09
The relationships of age changes in retinal pigment epithelium and Bruch's membrane. Invest Ophthalmol Vis Sci (1999) 1.09
Genotype-phenotype correlation in British families with X linked congenital stationary night blindness. Br J Ophthalmol (2003) 1.08
An autosomal recessive cone-rod dystrophy associated with amelogenesis imperfecta. J Med Genet (2004) 1.07
An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet (1998) 1.07
Multiple mechanisms are implicated in the generation of 5q35 microdeletions in Sotos syndrome. J Med Genet (2005) 1.06
Molecular analysis of eight mutations in FBN1. Hum Genet (1999) 1.04
RP1 protein truncating mutations predominate at the RP1 adRP locus. Invest Ophthalmol Vis Sci (2000) 1.04
Genetic mapping of X linked ocular albinism: linkage analysis in British families. J Med Genet (1992) 1.04
Phenotype of a British North Carolina macular dystrophy family linked to chromosome 6q. Br J Ophthalmol (1998) 1.03
A detailed study of the phenotype of an autosomal dominant cone-rod dystrophy (CORD7) associated with mutation in the gene for RIM1. Br J Ophthalmol (2005) 1.02
Differences in response to food stimuli in a rat model of obesity: in-vivo assessment of brain glucose metabolism. Int J Obes (Lond) (2008) 1.02
ADVIRC is caused by distinct mutations in BEST1 that alter pre-mRNA splicing. J Med Genet (2008) 1.00
Cognitive functioning in humans with mutations of the PAX6 gene. Neurology (2004) 1.00
Who should manage primary retinal detachments? Eye (Lond) (2000) 1.00
TIMP-3, collagen, and elastin immunohistochemistry and histopathology of Sorsby's fundus dystrophy. Invest Ophthalmol Vis Sci (2000) 0.99
Familial Alzheimer's disease with the amyloid precursor protein position 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology. Neurosci Lett (1992) 0.99
A review of primary hereditary optic neuropathies. J Inherit Metab Dis (2003) 0.98
Matrix metalloproteinase biology applied to vitreoretinal disorders. Br J Ophthalmol (2000) 0.98
Posterior polar cataract is the predominant consequence of a recurrent mutation in the PITX3 gene. Br J Ophthalmol (2005) 0.97
Localization of a gene (CORD7) for a dominant cone-rod dystrophy to chromosome 6q. Am J Hum Genet (1998) 0.97
Choroidal neovascularisation in children. Br J Ophthalmol (2008) 0.96
Symptomatic splenoma (hamartoma) of the spleen. A case report. Hippokratia (2010) 0.96
Correlation of MRI and neuropathology in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.96
Lisch nodules in neurofibromatosis type 2. Case report. Arch Ophthalmol (1989) 0.95
Cataract surgery and primary intraocular lens implantation in children < or = 2 years old in the UK and Ireland: finding of national surveys. Br J Ophthalmol (2009) 0.95
Pseudophakic retinal detachment. Graefes Arch Clin Exp Ophthalmol (1991) 0.94